Concepts (242)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Patellofemoral Joint | 13 | 2023 | 24 | 7.010 |
Why?
|
| Joint Instability | 15 | 2023 | 145 | 6.870 |
Why?
|
| Cartilage, Articular | 19 | 2023 | 163 | 5.250 |
Why?
|
| Knee Joint | 29 | 2023 | 284 | 4.990 |
Why?
|
| Patella | 12 | 2023 | 24 | 3.820 |
Why?
|
| Patellar Dislocation | 6 | 2023 | 13 | 3.170 |
Why?
|
| Allografts | 17 | 2022 | 74 | 2.670 |
Why?
|
| Shoulder Joint | 10 | 2023 | 228 | 2.610 |
Why?
|
| Bone Transplantation | 13 | 2023 | 82 | 2.500 |
Why?
|
| Humans | 86 | 2023 | 12240 | 2.430 |
Why?
|
| Knee Injuries | 11 | 2023 | 69 | 2.370 |
Why?
|
| Arthroscopy | 17 | 2022 | 267 | 2.280 |
Why?
|
| Anterior Cruciate Ligament Reconstruction | 11 | 2022 | 70 | 2.230 |
Why?
|
| Ligaments, Articular | 11 | 2023 | 50 | 2.080 |
Why?
|
| Cartilage Diseases | 9 | 2023 | 18 | 1.950 |
Why?
|
| Rotator Cuff Injuries | 7 | 2023 | 117 | 1.840 |
Why?
|
| Patellar Ligament | 3 | 2022 | 21 | 1.830 |
Why?
|
| Platelet-Rich Plasma | 4 | 2023 | 20 | 1.710 |
Why?
|
| Cadaver | 12 | 2023 | 166 | 1.610 |
Why?
|
| Tendons | 7 | 2022 | 74 | 1.520 |
Why?
|
| Tendon Injuries | 4 | 2022 | 81 | 1.510 |
Why?
|
| Retrospective Studies | 23 | 2023 | 1467 | 1.500 |
Why?
|
| Bankart Lesions | 2 | 2023 | 9 | 1.460 |
Why?
|
| Femur | 9 | 2022 | 190 | 1.450 |
Why?
|
| Transplantation, Homologous | 13 | 2022 | 93 | 1.290 |
Why?
|
| Osteoarthritis, Knee | 7 | 2022 | 169 | 1.270 |
Why?
|
| Adult | 33 | 2023 | 3557 | 1.180 |
Why?
|
| Biomechanical Phenomena | 11 | 2023 | 297 | 1.130 |
Why?
|
| Chondrocytes | 4 | 2020 | 58 | 1.130 |
Why?
|
| Tomography, X-Ray Computed | 7 | 2020 | 281 | 1.030 |
Why?
|
| Anterior Cruciate Ligament | 6 | 2022 | 76 | 1.020 |
Why?
|
| Suture Anchors | 3 | 2023 | 39 | 0.980 |
Why?
|
| Young Adult | 19 | 2023 | 863 | 0.960 |
Why?
|
| Anterior Cruciate Ligament Injuries | 7 | 2022 | 80 | 0.920 |
Why?
|
| Bone-Patellar Tendon-Bone Grafting | 3 | 2013 | 13 | 0.870 |
Why?
|
| Male | 33 | 2022 | 6815 | 0.820 |
Why?
|
| Shoulder Dislocation | 2 | 2022 | 47 | 0.820 |
Why?
|
| Patient Reported Outcome Measures | 12 | 2023 | 165 | 0.810 |
Why?
|
| Quality of Life | 3 | 2022 | 261 | 0.810 |
Why?
|
| Shoulder | 7 | 2022 | 92 | 0.810 |
Why?
|
| Arthritis | 2 | 2022 | 16 | 0.800 |
Why?
|
| Female | 31 | 2022 | 6974 | 0.780 |
Why?
|
| Meniscus | 2 | 2020 | 7 | 0.780 |
Why?
|
| Musculoskeletal Diseases | 1 | 2023 | 19 | 0.770 |
Why?
|
| Cartilage | 3 | 2021 | 41 | 0.750 |
Why?
|
| Fractures, Stress | 2 | 2020 | 11 | 0.740 |
Why?
|
| Surgeons | 2 | 2021 | 43 | 0.740 |
Why?
|
| Bone Diseases | 1 | 2022 | 9 | 0.730 |
Why?
|
| Menisci, Tibial | 7 | 2022 | 41 | 0.730 |
Why?
|
| Adolescent | 13 | 2023 | 989 | 0.720 |
Why?
|
| Bone Marrow | 2 | 2022 | 35 | 0.710 |
Why?
|
| Pain | 9 | 2023 | 193 | 0.700 |
Why?
|
| Rotator Cuff | 5 | 2023 | 108 | 0.690 |
Why?
|
| Arthroplasty, Replacement, Knee | 2 | 2022 | 264 | 0.690 |
Why?
|
| Suture Techniques | 5 | 2023 | 65 | 0.680 |
Why?
|
| Tibia | 6 | 2022 | 100 | 0.680 |
Why?
|
| Activities of Daily Living | 1 | 2022 | 182 | 0.670 |
Why?
|
| Middle Aged | 24 | 2022 | 4043 | 0.670 |
Why?
|
| Quadriceps Muscle | 1 | 2020 | 16 | 0.620 |
Why?
|
| Humeral Head | 3 | 2022 | 16 | 0.620 |
Why?
|
| Magnetic Resonance Imaging | 6 | 2022 | 464 | 0.620 |
Why?
|
| Follow-Up Studies | 13 | 2022 | 726 | 0.600 |
Why?
|
| Treatment Outcome | 15 | 2022 | 1478 | 0.600 |
Why?
|
| Fibrin Tissue Adhesive | 1 | 2019 | 1 | 0.590 |
Why?
|
| Tissue Adhesives | 1 | 2019 | 2 | 0.580 |
Why?
|
| Bone Resorption | 1 | 2019 | 55 | 0.560 |
Why?
|
| Imaging, Three-Dimensional | 5 | 2020 | 81 | 0.560 |
Why?
|
| Scapula | 1 | 2018 | 38 | 0.540 |
Why?
|
| Stifle | 1 | 2018 | 6 | 0.540 |
Why?
|
| Osteoporosis | 1 | 2018 | 51 | 0.520 |
Why?
|
| X-Ray Microtomography | 1 | 2018 | 67 | 0.520 |
Why?
|
| Tenodesis | 3 | 2022 | 53 | 0.480 |
Why?
|
| Return to Work | 3 | 2020 | 18 | 0.470 |
Why?
|
| Reproducibility of Results | 4 | 2021 | 324 | 0.470 |
Why?
|
| Computer Simulation | 3 | 2021 | 90 | 0.450 |
Why?
|
| Arthroplasty, Subchondral | 1 | 2014 | 14 | 0.430 |
Why?
|
| Range of Motion, Articular | 6 | 2020 | 278 | 0.420 |
Why?
|
| Orthopedic Procedures | 4 | 2018 | 111 | 0.400 |
Why?
|
| Animals | 7 | 2022 | 2092 | 0.400 |
Why?
|
| Osteotomy | 4 | 2022 | 66 | 0.380 |
Why?
|
| Gamma Rays | 1 | 2013 | 8 | 0.380 |
Why?
|
| Reoperation | 8 | 2021 | 366 | 0.330 |
Why?
|
| Risk Factors | 4 | 2021 | 1049 | 0.330 |
Why?
|
| Return to Sport | 3 | 2019 | 45 | 0.310 |
Why?
|
| Sports Medicine | 2 | 2022 | 17 | 0.300 |
Why?
|
| Osteochondritis Dissecans | 2 | 2019 | 11 | 0.260 |
Why?
|
| Bone and Bones | 2 | 2018 | 83 | 0.240 |
Why?
|
| Femoracetabular Impingement | 2 | 2020 | 50 | 0.240 |
Why?
|
| Aged | 9 | 2021 | 4000 | 0.230 |
Why?
|
| Weight-Bearing | 2 | 2018 | 72 | 0.230 |
Why?
|
| Transplantation, Autologous | 4 | 2020 | 42 | 0.230 |
Why?
|
| Postoperative Period | 3 | 2020 | 118 | 0.220 |
Why?
|
| Patient Satisfaction | 3 | 2021 | 118 | 0.220 |
Why?
|
| Arm | 2 | 2022 | 30 | 0.210 |
Why?
|
| Arthroplasty | 2 | 2023 | 54 | 0.210 |
Why?
|
| Ligaments | 1 | 2023 | 6 | 0.200 |
Why?
|
| Second-Look Surgery | 2 | 2020 | 7 | 0.190 |
Why?
|
| Minimal Clinically Important Difference | 2 | 2021 | 30 | 0.190 |
Why?
|
| Child | 2 | 2022 | 614 | 0.190 |
Why?
|
| Radiography | 2 | 2021 | 258 | 0.190 |
Why?
|
| Neurosurgical Procedures | 1 | 2023 | 57 | 0.190 |
Why?
|
| Muscle, Skeletal | 2 | 2022 | 201 | 0.190 |
Why?
|
| Fractures, Bone | 1 | 2023 | 37 | 0.180 |
Why?
|
| Ossification, Heterotopic | 1 | 2022 | 22 | 0.180 |
Why?
|
| Pain, Postoperative | 2 | 2022 | 146 | 0.180 |
Why?
|
| Posterior Cruciate Ligament Reconstruction | 1 | 2022 | 2 | 0.180 |
Why?
|
| Glenoid Cavity | 1 | 2022 | 16 | 0.180 |
Why?
|
| Electrosurgery | 1 | 2021 | 3 | 0.170 |
Why?
|
| Sheep | 1 | 2021 | 9 | 0.170 |
Why?
|
| Surgical Instruments | 1 | 2021 | 10 | 0.170 |
Why?
|
| Postoperative Complications | 3 | 2020 | 385 | 0.170 |
Why?
|
| Recurrence | 1 | 2021 | 126 | 0.170 |
Why?
|
| Rotation | 1 | 2021 | 54 | 0.170 |
Why?
|
| Cross-Sectional Studies | 1 | 2022 | 400 | 0.170 |
Why?
|
| Computers | 1 | 2021 | 9 | 0.170 |
Why?
|
| Debridement | 2 | 2018 | 31 | 0.170 |
Why?
|
| Epiphyses | 1 | 2020 | 4 | 0.160 |
Why?
|
| Intra-Articular Fractures | 1 | 2020 | 5 | 0.160 |
Why?
|
| Perioperative Period | 1 | 2020 | 6 | 0.160 |
Why?
|
| Shoulder Injuries | 2 | 2019 | 49 | 0.160 |
Why?
|
| Growth Plate | 1 | 2019 | 8 | 0.150 |
Why?
|
| Bone Marrow Cells | 1 | 2020 | 40 | 0.150 |
Why?
|
| Cattle | 2 | 2018 | 54 | 0.150 |
Why?
|
| Psychometrics | 1 | 2020 | 95 | 0.150 |
Why?
|
| Bone Screws | 1 | 2019 | 59 | 0.150 |
Why?
|
| Desiccation | 1 | 2019 | 1 | 0.150 |
Why?
|
| Motion Therapy, Continuous Passive | 1 | 2019 | 3 | 0.150 |
Why?
|
| Biological Products | 1 | 2019 | 16 | 0.150 |
Why?
|
| Software | 1 | 2019 | 26 | 0.140 |
Why?
|
| Analgesics, Opioid | 1 | 2020 | 109 | 0.140 |
Why?
|
| Image Interpretation, Computer-Assisted | 1 | 2019 | 38 | 0.140 |
Why?
|
| Anesthetics, Local | 2 | 2009 | 45 | 0.140 |
Why?
|
| Tissue Banks | 1 | 2018 | 3 | 0.140 |
Why?
|
| Quality Improvement | 1 | 2018 | 78 | 0.130 |
Why?
|
| Athletes | 1 | 2017 | 30 | 0.130 |
Why?
|
| Pain Measurement | 4 | 2020 | 211 | 0.120 |
Why?
|
| Sodium Chloride | 1 | 2016 | 16 | 0.120 |
Why?
|
| ROC Curve | 3 | 2020 | 78 | 0.120 |
Why?
|
| Disease Models, Animal | 1 | 2018 | 338 | 0.120 |
Why?
|
| Soft Tissue Injuries | 1 | 2016 | 8 | 0.120 |
Why?
|
| Amnion | 1 | 2015 | 2 | 0.120 |
Why?
|
| Time-to-Treatment | 1 | 2015 | 14 | 0.110 |
Why?
|
| Humerus | 1 | 2015 | 48 | 0.110 |
Why?
|
| Wound Healing | 1 | 2014 | 55 | 0.110 |
Why?
|
| Elbow Joint | 1 | 2015 | 52 | 0.100 |
Why?
|
| Joint Diseases | 1 | 2014 | 44 | 0.100 |
Why?
|
| Cohort Studies | 3 | 2021 | 827 | 0.100 |
Why?
|
| Athletic Injuries | 2 | 2013 | 73 | 0.100 |
Why?
|
| Prospective Studies | 4 | 2021 | 817 | 0.100 |
Why?
|
| Stress, Mechanical | 1 | 2013 | 86 | 0.100 |
Why?
|
| Pectoralis Muscles | 1 | 2013 | 10 | 0.100 |
Why?
|
| Postoperative Care | 2 | 2013 | 43 | 0.100 |
Why?
|
| Radiographic Image Interpretation, Computer-Assisted | 1 | 2012 | 21 | 0.090 |
Why?
|
| Baseball | 1 | 2013 | 30 | 0.090 |
Why?
|
| Tendon Transfer | 1 | 2012 | 6 | 0.090 |
Why?
|
| Femur Head | 1 | 2012 | 20 | 0.090 |
Why?
|
| Acetabulum | 1 | 2012 | 81 | 0.090 |
Why?
|
| Tissue Transplantation | 2 | 2008 | 9 | 0.090 |
Why?
|
| Time Factors | 3 | 2019 | 695 | 0.080 |
Why?
|
| Graft Survival | 3 | 2017 | 44 | 0.080 |
Why?
|
| Multivariate Analysis | 2 | 2020 | 141 | 0.080 |
Why?
|
| Odds Ratio | 2 | 2020 | 115 | 0.080 |
Why?
|
| Hyaluronic Acid | 2 | 2021 | 23 | 0.070 |
Why?
|
| Injections, Intra-Articular | 2 | 2021 | 31 | 0.070 |
Why?
|
| Methylprednisolone | 1 | 2009 | 10 | 0.070 |
Why?
|
| Lidocaine | 1 | 2009 | 17 | 0.070 |
Why?
|
| Drug Therapy, Combination | 1 | 2009 | 76 | 0.070 |
Why?
|
| Tissue Engineering | 1 | 2008 | 16 | 0.070 |
Why?
|
| Anti-Inflammatory Agents | 1 | 2009 | 39 | 0.070 |
Why?
|
| Tendinopathy | 1 | 2008 | 11 | 0.070 |
Why?
|
| Shoulder Pain | 1 | 2008 | 24 | 0.070 |
Why?
|
| Bupivacaine | 1 | 2008 | 27 | 0.070 |
Why?
|
| Intercellular Signaling Peptides and Proteins | 1 | 2008 | 28 | 0.070 |
Why?
|
| Bone Morphogenetic Proteins | 1 | 2008 | 39 | 0.070 |
Why?
|
| Transforming Growth Factor beta | 1 | 2008 | 54 | 0.070 |
Why?
|
| Insulin-Like Growth Factor I | 1 | 2008 | 36 | 0.070 |
Why?
|
| Ontario | 2 | 2017 | 9 | 0.060 |
Why?
|
| United States | 2 | 2021 | 989 | 0.060 |
Why?
|
| Recovery of Function | 2 | 2020 | 118 | 0.060 |
Why?
|
| Cyclooxygenase 2 Inhibitors | 1 | 2022 | 15 | 0.050 |
Why?
|
| Documentation | 1 | 2022 | 13 | 0.040 |
Why?
|
| Anti-Inflammatory Agents, Non-Steroidal | 1 | 2022 | 46 | 0.040 |
Why?
|
| Upper Extremity | 1 | 2021 | 10 | 0.040 |
Why?
|
| Elbow | 1 | 2021 | 13 | 0.040 |
Why?
|
| Network Meta-Analysis | 1 | 2021 | 6 | 0.040 |
Why?
|
| Workers' Compensation | 1 | 2021 | 28 | 0.040 |
Why?
|
| Information Systems | 1 | 2021 | 4 | 0.040 |
Why?
|
| Adrenal Cortex Hormones | 1 | 2021 | 55 | 0.040 |
Why?
|
| Area Under Curve | 1 | 2020 | 39 | 0.040 |
Why?
|
| Sports | 1 | 2020 | 20 | 0.040 |
Why?
|
| Meniscectomy | 1 | 2020 | 4 | 0.040 |
Why?
|
| Preoperative Period | 1 | 2020 | 34 | 0.040 |
Why?
|
| Symptom Assessment | 1 | 2020 | 10 | 0.040 |
Why?
|
| Logistic Models | 1 | 2020 | 196 | 0.040 |
Why?
|
| Morphine | 1 | 2020 | 40 | 0.040 |
Why?
|
| Aged, 80 and over | 2 | 2018 | 2152 | 0.040 |
Why?
|
| Kaplan-Meier Estimate | 1 | 2019 | 85 | 0.040 |
Why?
|
| Arthralgia | 1 | 2020 | 56 | 0.040 |
Why?
|
| Fracture Fixation, Internal | 1 | 2019 | 33 | 0.040 |
Why?
|
| Ankle | 1 | 2019 | 14 | 0.040 |
Why?
|
| Ankle Joint | 1 | 2019 | 21 | 0.040 |
Why?
|
| Aggrecans | 1 | 2019 | 26 | 0.040 |
Why?
|
| Proteoglycans | 1 | 2019 | 59 | 0.040 |
Why?
|
| Lysholm Knee Score | 1 | 2018 | 3 | 0.040 |
Why?
|
| Tissue Donors | 1 | 2019 | 42 | 0.040 |
Why?
|
| Cryopreservation | 1 | 2018 | 6 | 0.040 |
Why?
|
| Incidence | 1 | 2018 | 338 | 0.030 |
Why?
|
| Case-Control Studies | 1 | 2017 | 256 | 0.030 |
Why?
|
| Orthopedic Fixation Devices | 1 | 2016 | 11 | 0.030 |
Why?
|
| Arthroplasty, Replacement, Shoulder | 1 | 2017 | 93 | 0.030 |
Why?
|
| Injury Severity Score | 1 | 2013 | 8 | 0.020 |
Why?
|
| Acute Disease | 1 | 2013 | 90 | 0.020 |
Why?
|
| Risk Assessment | 1 | 2013 | 295 | 0.020 |
Why?
|
| Hip Joint | 1 | 2012 | 136 | 0.020 |
Why?
|
| Statistics, Nonparametric | 1 | 2010 | 72 | 0.020 |
Why?
|
| Analysis of Variance | 1 | 2010 | 125 | 0.020 |
Why?
|
| Regression Analysis | 1 | 2010 | 105 | 0.020 |
Why?
|
| Health Status Indicators | 1 | 2010 | 38 | 0.020 |
Why?
|
| Chondromalacia Patellae | 1 | 2009 | 1 | 0.020 |
Why?
|
| Anesthetics | 1 | 2009 | 13 | 0.020 |
Why?
|
| Tibial Meniscus Injuries | 1 | 2009 | 22 | 0.020 |
Why?
|
| Tissue Scaffolds | 1 | 2008 | 15 | 0.020 |
Why?
|
| Graft Rejection | 1 | 2008 | 30 | 0.020 |
Why?
|
| Substance P | 1 | 2008 | 6 | 0.020 |
Why?
|
| Calcitonin Gene-Related Peptide | 1 | 2008 | 7 | 0.020 |
Why?
|
| Double-Blind Method | 1 | 2009 | 166 | 0.020 |
Why?
|
| Axons | 1 | 2008 | 10 | 0.020 |
Why?
|
| Rupture | 1 | 2008 | 41 | 0.020 |
Why?
|
| Biocompatible Materials | 1 | 2008 | 42 | 0.020 |
Why?
|
| Random Allocation | 1 | 2008 | 59 | 0.020 |
Why?
|
| Bone Morphogenetic Protein 7 | 1 | 2008 | 16 | 0.020 |
Why?
|
| Rabbits | 1 | 2008 | 110 | 0.020 |
Why?
|
| Clinical Trials as Topic | 1 | 2008 | 100 | 0.020 |
Why?
|
| Immunohistochemistry | 1 | 2008 | 171 | 0.020 |
Why?
|
| Treatment Failure | 1 | 2008 | 58 | 0.020 |
Why?
|
| Sensitivity and Specificity | 1 | 2008 | 252 | 0.020 |
Why?
|
| Chronic Disease | 1 | 2008 | 186 | 0.020 |
Why?
|
| Cells, Cultured | 1 | 2008 | 275 | 0.020 |
Why?
|
| Prognosis | 1 | 2008 | 363 | 0.020 |
Why?
|
| Minimally Invasive Surgical Procedures | 1 | 2008 | 142 | 0.020 |
Why?
|
| Palliative Care | 1 | 2007 | 53 | 0.020 |
Why?
|
| Algorithms | 1 | 2007 | 169 | 0.020 |
Why?
|